News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,300 Results
Type
Article (43575)
Company Profile (290)
Press Release (698419)
Multimedia
Podcasts (102)
Webinars (23)
Section
Business (209034)
Career Advice (2091)
Deals (36215)
Drug Delivery (144)
Drug Development (82234)
Employer Resources (174)
FDA (16881)
Job Trends (15529)
News (353765)
Policy (33961)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2639)
Accelerated approval (43)
Adcomms (25)
Allergies (162)
Alliances (51021)
ALS (194)
Alzheimer's disease (1748)
Antibody-drug conjugate (ADC) (373)
Approvals (17181)
Artificial intelligence (605)
Autoimmune disease (230)
Automation (52)
Bankruptcy (366)
Best Places to Work (11830)
BIOSECURE Act (21)
Biosimilars (205)
Biotechnology (189)
Bladder cancer (180)
Brain cancer (63)
Breast cancer (685)
Cancer (5338)
Cardiovascular disease (447)
Career advice (1768)
Career pathing (42)
CAR-T (310)
CDC (55)
Celiac Disease (2)
Cell therapy (826)
Cervical cancer (41)
Clinical research (70715)
Collaboration (1930)
Company closure (5)
Compensation (1254)
Complete response letters (80)
COVID-19 (2829)
CRISPR (100)
C-suite (982)
Cystic fibrosis (147)
Data (7050)
Decentralized trials (3)
Denatured (30)
Depression (155)
Dermatology (57)
Diabetes (561)
Diagnostics (6899)
Digital health (51)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (299)
Drug pricing (215)
Drug shortages (35)
Duchenne muscular dystrophy (267)
Earnings (92301)
Editorial (65)
Employer branding (21)
Employer resources (153)
Events (120435)
Executive appointments (1044)
FDA (20312)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1621)
Gene editing (214)
Generative AI (52)
Gene therapy (671)
GLP-1 (1078)
Government (4868)
Grass and pollen (7)
Guidances (397)
Healthcare (19156)
HIV (75)
Huntington's disease (53)
IgA nephropathy (91)
Immunology and inflammation (278)
Immuno-oncology (81)
Indications (156)
Infectious disease (3148)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (130)
Intellectual property (276)
Interviews (329)
IPO (16833)
IRA (56)
Job creations (4028)
Job search strategy (1475)
JPM (60)
Kidney cancer (18)
Labor market (92)
Layoffs (581)
Leadership (35)
Legal (8227)
Liver cancer (97)
Longevity (28)
Lung cancer (715)
Lymphoma (410)
Machine learning (52)
Management (59)
Manufacturing (992)
MASH (176)
Medical device (14260)
Medtech (14340)
Mergers & acquisitions (20537)
Metabolic disorders (1453)
mRNA (183)
Multiple sclerosis (175)
NASH (17)
Neurodegenerative disease (384)
Neuropsychiatric disorders (96)
Neuroscience (3150)
Neurotech (1)
NextGen: Class of 2026 (6654)
Non-profit (4570)
Now hiring (73)
Obesity (695)
Opinion (293)
Ovarian cancer (183)
Pain (226)
Pancreatic cancer (258)
Parkinson's disease (338)
Partnered (35)
Patents (552)
Patient recruitment (583)
Peanut (60)
People (60219)
Pharmaceutical (66)
Pharmacy benefit managers (35)
Phase 1 (22083)
Phase 2 (31113)
Phase 3 (23196)
Pipeline (7098)
Policy (322)
Postmarket research (2589)
Preclinical (9364)
Press Release (67)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (312)
Rare diseases (1002)
Real estate (6358)
Recruiting (71)
Regulatory (25807)
Reports (54)
Research institute (2451)
Resumes & cover letters (357)
Rett syndrome (32)
RNA editing (17)
RSV (87)
Schizophrenia (165)
Series A (271)
Series B (202)
Service/supplier (12)
Sickle cell disease (106)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (45)
Startups (3709)
State (2)
Stomach cancer (18)
Supply chain (123)
Tariffs (95)
The Weekly (69)
Vaccines (1088)
Venture capital (99)
Weight loss (458)
Women's health (108)
Worklife (19)
Date
Today (83)
Last 7 days (635)
Last 30 days (2779)
Last 365 days (30419)
2026 (7891)
2025 (30633)
2024 (35663)
2023 (40582)
2022 (51750)
2021 (56380)
2020 (54895)
2019 (47472)
2018 (35807)
2017 (32935)
2016 (32377)
2015 (38484)
2014 (32162)
2013 (27231)
2012 (29521)
2011 (30271)
2010 (28137)
Location
Africa (771)
Alabama (94)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (41272)
Australia (6665)
California (12286)
Canada (3513)
China (1244)
Colorado (522)
Connecticut (521)
Delaware (366)
Europe (89182)
Florida (1857)
Georgia (395)
Hawaii (3)
Idaho (64)
Illinois (973)
India (82)
Indiana (565)
Iowa (23)
Japan (492)
Kansas (131)
Kentucky (45)
Louisiana (38)
Maine (85)
Maryland (1511)
Massachusetts (8797)
Michigan (348)
Minnesota (677)
Mississippi (7)
Missouri (140)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (87)
New Jersey (3272)
New Mexico (30)
New York (3239)
North Carolina (1562)
North Dakota (10)
Northern California (6070)
Ohio (371)
Oklahoma (23)
Oregon (42)
Pennsylvania (2493)
Puerto Rico (25)
Rhode Island (50)
South America (1171)
South Carolina (76)
South Dakota (1)
Southern California (4822)
Tennessee (198)
Texas (1948)
United States (43646)
Utah (368)
Vermont (1)
Virginia (293)
Washington D.C. (83)
Washington State (986)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
742,300 Results for "genesis electronics manufacturing inc gem".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
February 3, 2026
·
5 min read
Manufacturing
UCB Investing $2B To Build Manufacturing Facility in Georgia
The Belgian drugmaker plans to hire about 330 people at a facility that will use advanced manufacturing technologies including AI, robotics and automation to meet rising demand for key products. This will be UCB’s first biologics manufacturing facility in the U.S.
March 25, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs
April 1, 2026
·
2 min read
Press Releases
Kenox Pharmaceuticals Inc. Announces Clinical Manufacturing Readiness for Nasal and Inhaled Drug Products
March 5, 2026
·
2 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
Curiteva Announces Plans for Innovation Center & Increase in Inspire Manufacturing
April 1, 2026
·
2 min read
Manufacturing
As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
February 3, 2026
·
4 min read
·
Nick Paul Taylor
Manufacturing
Generic Drug and API Manufacturers Call for Onshoring Incentives
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for domestic drug manufacturing.
November 4, 2025
·
4 min read
·
Nick Paul Taylor
Press Releases
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
January 7, 2026
·
4 min read
Press Releases
Genesys Spine Announces Positive Prospective Study Results for SIros® Lateral SI Joint Fusion System
February 8, 2026
·
2 min read
1 of 74,230
Next
